Does Asbestos Cause Prostate Cancer?

Asbestos is a group of mineral fibers that has been widely used in construction and industrial materials. However, asbestos exposure is known to cause serious health problems, including cancers and chronic respiratory diseases. According to the World Health Organization (WHO), asbestos causes more than 200,000 deaths worldwide each year.

One question that has recently drawn attention is the possible link between asbestos and prostate cancer. Does asbestos exposure actually cause prostate cancer, or is it simply one of several factors that may be associated with an increased risk?

Can we say asbestos causes prostate cancer?

The answer is not definitive. Asbestos exposure may be associated with prostate cancer, but this does not mean that asbestos is a direct or primary cause of the disease.

Introduction: Why is this association being discussed?

Asbestos is a well-established carcinogen, but whether it increases the risk of prostate cancer remains uncertain.

Over time, some studies and content have discussed a possible association between asbestos exposure and prostate cancer. However, findings have been inconsistent across studies, making careful and accurate interpretation necessary.

What cancers are clearly associated with asbestos?

The main cancer types known to be associated with asbestos exposure are:

1. Malignant mesothelioma (most common)

2. lung cancer

3. laryngeal cancer

4. ovarian cancer

People who are regularly exposed to asbestos over a long period of time may have an increased risk of developing these types of cancer. When asbestos fibers are inhaled, some can remain in the lungs and accumulate over time. This can cause chronic inflammation and tissue damage, which may eventually contribute to respiratory problems and other health issues.

Why is asbestos suspected to be linked to prostate cancer?

Several biological mechanisms have been proposed, but none has been conclusively demonstrated for prostate cancer.

Some occupations involve relatively high levels of asbestos exposure, including shipbuilding, construction, and insulation work.

Some studies have reported an increased incidence of prostate cancer among workers in these industries. Other studies have also investigated whether asbestos fibers may contribute to chronic inflammation and oxidative stress.

What do the meta-analyses show?

Study	Year	Studies included	Main result	Conclusion
Dutheil et al.	2020	33	Approximately 10% increased risk reported	Possible association but further studies required
Godono et al.	2022	65	No significant association	Association not confirmed

*Some cited meta-analyses could have been retracted.

Why are the results inconsistent?

Exposure misclassification may be one reason. Many studies classified asbestos exposure based on occupation, industry, or residential history rather than actual asbestos concentrations or cumulative exposure levels.

Occupational classification also does not exclude exposure to other hazardous substances. Workers exposed to asbestos may have also been exposed to other substances that could potentially contribute to cancer risk.

It is therefore difficult to conclude that asbestos exposure directly increases the risk of prostate cancer. Many studies have reported an increased risk of approximately 7-10%, which is relatively small and may be influenced by factors such as screening frequency, age, occupation, lifestyle, and other variables.

What is the current conclusion?

Current evidence does not establish asbestos exposure as a direct cause of prostate cancer, although a small association may exist.

Some observational studies have reported a modest increase in prostate cancer risk among people exposed to asbestos. However, the findings remain inconsistent and may be influenced by various other factors.

References:

1. https://www.who.int/news-room/fact-sheets/detail/asbestos

2. https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/asbestos

3. https://www.mdanderson.org/cancerwise/asbestos-exposure-and-cancer--8-things-to-know.h00-159773289.html

4. https://pubmed.ncbi.nlm.nih.gov/32097115/

5. https://pubmed.ncbi.nlm.nih.gov/34413482/

---

FREND 2.0

A microfluidic immunofluorescence analyzer

KEY FEATURES & BENEFITS

- QR code/barcode scanner

- Built-in thermal printer

- Rapid quantitative immunoassay

- Small sample volume analysis

- LIS/HIS Available

PSA Plus

Fast and accurate quantitative in vitro diagnostic of Prostate-specific antigen (PSA)

KEY FEATURES & BENEFITS

- Cleared by the FDA 510(k)

- Measures the level of PSA to monitor (or manage) patients with prostate cancer

- Quantitative in vitro diagnostic of the protein in human serum or plasma based on the lab-on-a-chip